Scholarlink

Objective <p>This study examines associations between opioid use disorder (OUD) treatment and pregnancy outcomes among Medicaid enrollees.</p> Study design <p>Using 2021 Medicaid claims, we identified 29,193 women with OUD and a pregnancy-related outcome receiving (1) Medication Only, (2) Behavioral Therapy Only, (3) Medication and Behavioral Therapy, or (4) No Treatment. Multivariable logistic regression estimated adjusted odds ratios (ORs) for outcomes.</p> Results <p>Among pregnant women with OUD, over half (52.5%) received no treatment; 27.9% received medication and therapy, 12.5% received medication only, and 7.0% received therapy only. Any form of treatment was linked to reduced risk of fetal death. Medication, alone or with therapy, was associated with lower risk of preterm labor, and medication alone was linked to reduced risk of abruptio placentae.</p> Conclusion <p>Receiving treatment for OUD is significantly associated with better pregnancy outcomes. Expanding access to medication for OUD and integrating therapy are crucial for improving maternal health.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Associations between maternal opioid use disorder treatment and pregnancy outcomes

  • 期刊论文

  • 发表日期：

    2025年11月11日

查看全文
  • Mustafa Karakus,
  • Rikki Welch,
  • Meg Tucker,
  • Tanvi Rao,
  • Peter Lee,
  • Cristian Ilie,
  • Sushmita Shoma Ghose

摘要

Objective

This study examines associations between opioid use disorder (OUD) treatment and pregnancy outcomes among Medicaid enrollees.

Study design

Using 2021 Medicaid claims, we identified 29,193 women with OUD and a pregnancy-related outcome receiving (1) Medication Only, (2) Behavioral Therapy Only, (3) Medication and Behavioral Therapy, or (4) No Treatment. Multivariable logistic regression estimated adjusted odds ratios (ORs) for outcomes.

Results

Among pregnant women with OUD, over half (52.5%) received no treatment; 27.9% received medication and therapy, 12.5% received medication only, and 7.0% received therapy only. Any form of treatment was linked to reduced risk of fetal death. Medication, alone or with therapy, was associated with lower risk of preterm labor, and medication alone was linked to reduced risk of abruptio placentae.

Conclusion

Receiving treatment for OUD is significantly associated with better pregnancy outcomes. Expanding access to medication for OUD and integrating therapy are crucial for improving maternal health.